LTBK-01: PROSPECTIVE, MULTI-CENTER PHASE III TRIAL OF TUMOR TREATING FIELDS TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

BACKGROUND: Tumor Treating Fields (TTFields) is an established, frequency-tuned, anti-mitotic, physical treatment modality that acts in metaphase, anaphase and telophase. TTFields are delivered to the brain by a patient operated, portable medical device (Optune™, Novocure Ltd.). An international, mu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Stupp, Roger, Idbaih, Ahmed, Steinberg, David M., Read, William, Toms, Steven, Barnett, Gene, Nicholas, Garth, Kim, Chae-Yong, Fink, Karen, Salmaggi, Andrea, Lieberman, Frank, Zhu, Jay, Taylor, Lynne, Stragliotto, Giuseppe, Hottinger, Andreas, Kirson, Eilon D., Weinberg, Uri, Palti, Yoram, Hegi, Monika E., Ram, Zvi
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Late Breaking Abstract
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5772218/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now260
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados